This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...
They’re the seemingly miraculous solution to weight loss, helping people shed stubborn pounds that other diet and food ...
Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...
Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...
Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in ...
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
Dr Ellen Fallows answers key questions on the prescribing of medications for weight loss in patients with obesity ...
Malay Mail on MSN
What are GLP-1 drugs? The diabetes medications now used as a weight loss ‘miracle’ — and why doctors are worried
KUALA LUMPUR, Feb 10 — Often referred to as a ‘miracle drug’, glucagon-like peptide-1 (GLP-1) ...
More than 1.6 million adults in England, Wales and Scotland used weight-loss drugs such as Wegovy and Mounjaro between early 2024 and early 2025.
THE number of people taking “fat jabs” such as Mounjaro and Ozempic is on the rise. However, they present serious risks to ...
The moment I administered my first weight-loss jab, I felt an overwhelming sense of relief. I'd been dieting since I was 15.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results